Sanjivani Paranteral Ltd.
₹224.3+4.35%Dec 16, 10:45 AM IST
SANJIVIN•Health Technology•Pharmaceuticals: Major
Current Price
₹224.3+4.35%
Dec 16, 10:45 AM ISTMarket Cap₹273.94 Cr
Market Cap₹273.94 Cr
Business Overview
Sanjivani Paranteral Limited operates through 2 main business divisions including Pharmaceutical Manufacturing, CDMO Services.
Business Hierarchy Structure for Sanjivani Paranteral Limited
- Sanjivani Paranteral Limited
- Pharmaceutical Manufacturing
- Injectables
- LincoSan (Lincomycin Injection USP 600 mg/2 ml)
- Meropenem Injection IP 1.0 gm PENEM
- Oral Solids
- Tablets
- SancoLax (Bisacodyl Tablets BP 5mg)
- Sanxamic (Tranexamic Acid Tablet BP 500 mg)
- Nutrisol D3 SK (Vitamin D3 5000 IU Tablet)
- Buscomine (Hyoscine Butylbromide Tablets BP 10 mg)
- Capsules
- GabaSan (Gabapentin Capsules BP 300 mg)
- Tablets
- Nutraceuticals
- Injectables
- CDMO Services
- Injectables Clients
- GLAND
- Kopran
- MACLEODS
- Oral & Nutraceuticals Clients
- VITABIOTICS
- Injectables Clients
- Pharmaceutical Manufacturing